Thursday, October 8, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleNasdaq· February 24, 2026

Stocks Rally as AI-Fueled Worries Ease

View original at nasdaq.com
Stocks Rally as AI-Fueled Worries Ease The S&P 500 Index ($SPX) (SPY) today is up +0.50%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.75%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.90%…
Opening lines of the source · Nasdaq · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Remains optimistic about more rate cuts in 2026 contingent on inflation progress to 2%

    80% confidence
  • Considering limited military strike on Iran to ramp up pressure on nuclear deal

    80% confidence
  • Q2 adjusted EPS forecast of $2.27 to $2.33

    80% confidence
  • US Feb consumer confidence index rose by 2.2 to 91.2

    80% confidence
  • 10 to 15 days is pretty much the maximum he would allow for Iran negotiations

    80% confidence
  • Upgraded Qualcomm to buy from hold with price target of $185

    80% confidence
  • Full-year revenue forecast of $5.8 to $6.0 billion

    80% confidence
  • S&P earnings growth expected to climb by 8.4% in Q4, marking tenth consecutive quarter of year-over-year growth

    80% confidence
  • Will deploy data center gear based on AMD processors worth double-digit billion dollars per gigawatt

    80% confidence
  • 2026 adjusted EBITDA forecast of $607 million

    80% confidence
  • Q4 earnings expected to increase by 4.6% excluding Magnificent Seven megacap tech stocks

    80% confidence
  • Upgraded Genuine Parts to strong buy from market perform with price target of $145

    80% confidence
  • Reached one million professional users of CoCounsel AI tool

    80% confidence
  • Threatened to raise global tariff rate to 15%

    80% confidence
  • Downgraded Cable One to underperform from neutral with price target of $80

    80% confidence
  • Full-year revenue forecast of $3.75 billion

    80% confidence
  • Good chance of diplomatic solution to Iran nuclear standoff

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com